Trial · NCT06237595
Vagus Nerve Stimulation in Fibromyalgia
NCT06237595, Not applicable, Completed, Kasr El Aini Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Vagus Nerve Stimulation in Fibromyalgia. Trials, record NCT06237595. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06237595
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Vagus Nerve Stimulation in Fibromyalgia
- NCT number
- NCT06237595
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 87 participants, actual
- Lead sponsor
- Kasr El Aini Hospital
- Conditions
- Fibromyalgia
- Interventions
- Vagus nerve stimulation, Medical treatment, Combined vagus nerve stimulation and medical treatment
- First posted
- 2024-02-01
- Last updated
- 2026-08-07
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Visual analogue scale 0-10 | 0,1,2 months | A 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme "worst pain imaginable". decrease i scale means improvement |
| Primary | Symptom severity scale score | 0,1,2 months | A 0-12 score denoting the severity of symptoms. decrease in the score means improvement. |
| Primary | Widespread pain index | 0,1,2 months | A 0 - 19 score denoting the number of areas the patient has had pain over the last week. decrease in value means improvement. |
| Primary | Fibromyalgia severity scale | 0,1,2 months | Is the sum of both widespread pain index, and symptom severity scale score. A decrease in value means improvement |
| Primary | Fibromyalgia impact questionnaire | 0,1,2 months | The Fibromyalgia Impact Questionnaire (FIQ) is a brief 10-item, that measures physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue, and well being in fibromyalgia patients. |
| Secondary | Beck anxiety scale | 0,1,2 months | a 21 -item self-report inventory for measuring the severity of anxiety. A decrease in value means improvement. |
| Secondary | Beck depression inventory | 0,1,2 months | A 21-item self-reporting questionnaire for evaluating the severity of depression in normal and psychiatric populations, decrease in the value means improvement |
| Secondary | Pittsburgh sleep quality index | 0,1,2 months | A 19 items idex, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06237595
GET https://conductscience.org/api/trials/v1/NCT06237595/registered